Literature DB >> 5420635

Clinical application of serum digitoxin levels. A simplified plasma determination.

J D Bentley, G H Burnett, R L Conklin, R H Wasserburger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420635     DOI: 10.1161/01.cir.41.1.67

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Beta-methyl-digoxin. V. Protein binding, tissue distribution and extra-cardiac effects in rats and mice.

Authors:  A Roesch; K Koch; W Schaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 3.  [Determination of digoxin and digitoxin in the blood and their clinical significance].

Authors:  G Bodem; H J Gilfrich
Journal:  Klin Wochenschr       Date:  1973-01-15

4.  Plasma concentrations of cardiac glycosides in digitalis intoxication.

Authors:  G Somogyi; A Káldor; A Jankovics
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

5.  [The inhibitory effect of cardiac glycosides on 86 Rb-uptake of erythrocytes. I. Studies on the determination of cymarin (k-strophantin-a) and digitoxin].

Authors:  G G Belz; K O Vollmer; J H Wissler
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

6.  Clinical use of a bio-assay of serum digitoxin activity.

Authors:  K Rasmussen; J Jervell; O Storstein
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

Authors:  T W Smith
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.